V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310008219 | 310005358 | 1.74 | 68 | Palliative (P) | 2017-04-11 | 2017-04-12 | Methotrexate High Dose (3g/m2) | N | N | 310025528 | OXALIPLATIN + MDG |
| 310008220 | 310008357 | null | 90.5 | Curative (C) | 2017-08-24 | 2017-09-21 | ICE-R (Cycle 2 onwards) | N | null | 310025547 | FLUDARABINE + MELPHALAN |
| 310008221 | 310005360 | 1.54 | null | Curative (C) | 2014-06-10 | 2014-07-10 | ICON8 TRIAL | 2 | N | 310025547 | METHOTREXATE HIGH DOSE |
| 310008222 | 310005361 | 1.66 | 82.5 | Disease modification (D) | 2015-01-17 | 2018-01-24 | DABRAFENIB | N | N | 310025578 | CAV |
| 310008223 | 310005361 | 1.59 | 83.3 | Palliative (P) | 2016-02-08 | 2016-03-21 | Ifosfamide | N | N | 310025578 | CAPECITABINE + CARBOPLATIN |
| 310008224 | 310005371 | 1.78 | 96.4 | Neo-adjuvant (N) | 2013-10-31 | 2013-11-18 | Enzalutamide | N | N | 310025617 | VIDE |
| 310008225 | 310005372 | null | 99.8 | Curative (C) | 2017-03-21 | 2017-03-21 | Alemtuzumab | 2 | N | 310025617 | FLUDARABINE + MELPHALAN |
| 310008226 | 310005373 | 1.56 | 67 | Disease modification (D) | 2016-11-14 | 2016-11-28 | LANREOTIDE | N | N | 310025661 | TOPOTECAN |
| 310008227 | 310005374 | 1.63 | 47.6 | Neo-adjuvant (N) | 2016-03-09 | 2016-03-10 | BCG Intravesical | N | N | 310025661 | CISPLATIN + FLUOROURACIL |
| 310008228 | 310005374 | 1.5 | 73.6 | null | 2017-11-29 | 2017-11-29 | Oxaliplatin + Modified de Gramont | N | N | 310025661 | OLAPARIB |
| 310008229 | 310011322 | 1.78 | 60.4 | Adjuvant (A) | 2015-11-04 | 2015-11-04 | ECX | 2 | N | 310025674 | ENZALUTAMIDE |
| 310008230 | 310005376 | 1.59 | 60 | Palliative (P) | 2013-07-21 | 2013-08-02 | FEC 60 or 75 | N | null | 310025683 | CISPLATIN + FLUOROURACIL |
| 310008231 | 310005377 | 1.53 | 59.75 | Palliative (P) | 2013-08-09 | 2013-09-06 | Docetaxel + Nintedanib | 2 | null | 310025687 | ICON TRIAL |
| 310008232 | 310008365 | 1.7 | 68 | Curative (C) | 2013-11-20 | 2013-11-29 | CAPECITABINE + RT | N | N | 310025700 | REGORAFENIB |
| 310008233 | 310005379 | 1.74 | 73.5 | Curative (C) | 2018-02-22 | 2018-03-03 | EP | N | N | 310025703 | IVE + METHOTREXATE |
| 310008234 | 310005381 | 1.64 | 59.75 | Curative (C) | 2015-09-01 | 2015-09-03 | BCG Intravesical | 2 | N | 310025710 | TOPOTECAN |
| 310008235 | 310005387 | null | 0 | Palliative (P) | 2014-02-10 | 2014-02-10 | Methotrexate High Dose (3g/m2) | N | null | 310025718 | DACARBAZINE |
| 310008236 | 310005388 | null | 54.1 | Curative (C) | 2014-09-26 | 2014-09-26 | CARBOPLATIN + RT | N | N | 310025719 | ALEMTUZUMAB |
| 310008237 | 310005394 | 1.92 | 118 | Curative (C) | 2013-07-25 | 2013-07-25 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 310025731 | ICE |
| 310008238 | 310005394 | 1.7 | 71 | Palliative (P) | 2017-10-14 | 2017-10-14 | STS Rhabdo RMS 2005 Vin Cyclo | Y | null | 310025731 | CAPECITABINE |
| 310008240 | 310005398 | 1.54 | 68.9 | null | 2015-05-01 | 2015-05-06 | CAPECITABINE + MITOMYCIN + RT | N | N | 310025753 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 310008241 | 310005398 | null | 63.9 | Palliative (P) | 2016-11-12 | 2016-12-30 | DOXORUBICIN | N | N | 310025753 | DABRAFENIB |
| 310008242 | 310005400 | 1.65 | 81.4 | Palliative (P) | 2015-07-03 | 2015-08-09 | RUXOLITINIB | 1 | null | 310000155 | MELPHALAN + TOPOTECAN |
| 310008243 | 310005400 | null | null | Palliative (P) | 2015-08-30 | 2016-03-08 | Cisplatin + Topotecan | null | null | 310000155 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 310008244 | 310005402 | 1.73 | null | Curative (C) | 2015-04-09 | 2015-05-12 | METHOTREXATE | N | N | 310000297 | RMS 2005 TRIAL |
| 310008245 | 310005403 | 1.82 | 66.8 | Curative (C) | 2015-12-07 | 2017-05-02 | CETUXIMAB + RT | N | N | 310000297 | ALL INTENSIFICATION |
| 310008246 | 310005404 | null | 79.3 | Neo-adjuvant (N) | 2016-10-06 | 2016-12-08 | Capecitabine (21days) + Carboplatin | N | N | 310000433 | CAPECITABINE + OXALIPLATIN |
| 310008247 | 310005407 | 1.64 | null | c | 2017-05-11 | 2017-05-14 | Alemtuzumab + Cyclophos TBI Allo | null | null | 310000469 | ICON TRIAL |
| 310008248 | 310005412 | 1.59 | 92.2 | Disease modification (D) | 2017-02-19 | 2017-02-21 | ECHELON-2 TRIAL | 02 | N | 310000475 | MPV |
| 310008249 | 310008384 | 1.84 | null | Neo-adjuvant (N) | 2018-10-06 | 2018-10-14 | LENALIDOMIDE | 02 | N | 310000475 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL |
| 310008250 | 310005417 | 1.62 | 61 | Curative (C) | 2016-10-18 | 2016-10-26 | IVE-R | 02 | N | 310000661 | CISPLATIN + FLUOROURACIL |
| 310008251 | 310005418 | 1.7 | 83.3 | Disease modification (D) | 2017-05-17 | 2017-05-17 | TEMOZOLOMIDE | 02 | null | 310000778 | CVP |
| 310008252 | 310005418 | 1.82 | 101 | Palliative (P) | 2019-05-26 | 2019-06-18 | Dacarbazine | N | N | 310000778 | CHLORAMBUCIL + DEXAMETHASONE + ETOPOSIDE |
| 310008253 | 310005420 | 1.81 | 107.5 | Curative (C) | null | 2016-10-22 | GEMCITABINE + RITUXIMAB | N | N | 310000909 | ICE-R |
| 310008254 | 310005420 | 1.72 | 73.6 | Curative (C) | 2015-03-10 | 2015-07-17 | ECX | N | N | 310000909 | CAPECITABINE |
| 310008255 | 310005422 | 1.73 | 59.5 | null | 2017-09-24 | 2017-11-08 | Sunitinib | null | null | 310001118 | CYCLO + DOXORUBICIN + VINCRISTINE |
| 310008256 | 310005426 | null | 71 | Curative (C) | 2013-08-15 | 2013-08-15 | Irinotecan + Modified De Gramont | N | N | 310001147 | DHAP |
| 310008257 | 310005427 | 1.63 | 63 | Not known (9) | 2015-04-22 | 2015-05-19 | LANREOTIDE | 02 | N | 310001246 | OLAPARIB |
| 310008258 | 310005428 | 1.63 | null | Palliative (P) | 2015-08-05 | 2015-09-16 | CTW | null | null | 310001253 | DACARBAZINE + GEMCITABINE |
| 310008259 | 310009971 | 1.85 | 85 | Curative (C) | 2017-07-06 | 2017-07-06 | GC Int Guide Excranial GermCell JEB | 02 | N | 310001253 | PEG INTERFERON |
| 310008260 | 310005429 | 1.59 | null | Palliative (P) | 2018-06-10 | 2018-07-01 | CETUXIMAB | N | N | 310001330 | CETUXIMAB + RT |
| 310008261 | 310005431 | null | null | Palliative (P) | 2014-12-09 | 2015-05-17 | Nelarabine | null | null | 310001357 | CAPECITABINE + OXALIPLATIN |
| 310008262 | 310005432 | null | 99 | Palliative (P) | 2018-12-03 | 2018-12-11 | Ifosfamide | N | N | 310001395 | METHOTREXATE HIGH DOSE |
| 310008263 | 310008392 | 1.81 | 109 | Curative (C) | 2014-04-03 | 2014-08-20 | CODOX M + IVAC | N | N | 310001427 | R IVAC |
| 310008264 | 310005434 | 1.55 | null | Palliative (P) | 2017-12-03 | 2017-12-12 | Oxaliplatin + Modified de Gramont | Y | N | 310001463 | CLADRIBINE |
| 310008265 | 310008393 | 1.65 | 54.5 | Palliative (P) | 2016-05-16 | 2016-06-24 | Topotecan (intravenous) | N | Y | 310001592 | GEMCITABINE + TREOSULPHAN |
| 310008266 | 310005435 | null | 64 | Adjuvant (A) | 2015-01-15 | 2015-02-22 | NIVOLUMAB | N | N | 310001616 | BCG |
| 310008267 | 310005436 | 1.66 | null | Palliative (P) | 2015-09-26 | 2016-01-23 | Capecitabine + Cisplatin | null | null | 310001625 | HYDROXYCARBAMIDE |
| 310008268 | 310008394 | 1.81 | null | null | null | 2019-03-21 | Triple Intrathecal | 02 | null | 310001625 | DOXORUBICIN |
| 310008269 | 310005437 | 1.75 | 86.4 | Curative (C) | 2017-08-01 | 2017-08-02 | Cetuximab + Radiotherapy Load | 2 | N | 310001682 | FCR |